Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial
PaperCitations, authors & open-access status
First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 234 citations, 2012 year and bronze oa status.
234
Citations
2012
Year
bronze
OA Status